Drug Database
BE

bendazac lysinate (bendaline / Bendalina, lysinate / bendazac lysinate)

✓ Approved

Casasco · Small Molecule · Small Molecule

What is bendazac lysinate?

bendazac lysinate is a small molecule developed by Casasco. It is approved for therapeutic indications via others or topical.

Drug Profile

Brand Namesbendaline, Bendalina, lysinate, bendazac lysinate
CompanyCasasco
Drug ClassSmall Molecule
RouteOthers, Topical
StatusApproved

Therapeutic Indications

bendazac lysinate is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Eye disordersCataract✓ Approved

Related Research Articles

PubMedBiotechnology for biofuels and bioproducts2026-03-04

Evaluating isoprenol production using the IPP-bypass pathway in the oleaginous yeast Rhodosporidium toruloides.

Garcia Valentina E VE, Geiselman Gina M GM, Hwang Hee Jin HJ, Chen Yan Y et al.

To strengthen the national energy supply, there is an increasing demand for domestically generated aviation fuels. Bio-derived advanced aviation fuels offer the opportunity to meet this domestic need while presenting a unique opportunity to investigate the production of novel aviation fuels. Isoprenol, a chemical precursor to such novel fuels, has been shown to be a biologically producible compound in model organisms, but its bio-producibility needs to be further explored in organisms more compatible with industrial bioproduction. In this work, we evaluate isoprenol production using the promising bioproduction yeast, Rhodosporidium toruloides. First, we show successful isoprenol production using the IPP-bypass pathways most successful in laboratory strains of E. coli and S. cerevisiae. Next, we demonstrate that increased flux through the mevalonate pathway only modestly increases isoprenol titers. Using proteomics, we identified a potential bottleneck in production at the final step in the IPP-bypass pathway and explored alternative enzymes for this step. Finally, the top three strains of R. toruloides were evaluated in sorghum hydrolysates generated using cholinium lysinate. Through this work, 93.1 mg/L of isoprenol was produced in mock medium and 27.3 mg/L in sorghum hydrolysates. Together these results lay the foundation for future work for the production of isoprenol from bioproduction crops.

PubMedEFSA journal. European Food Safety Authority2026-02-26

Safety and efficacy of a feed additive consisting of zinc-lysinate sulfate for all animal species (Phytobiotics Futterzusatzstoffe GmbH).

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa Roberto Edoardo RE, Azimonti Giovanna G, Bonos Eleftherios E et al.

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of Zinc-lysinate sulfate (Plexomin® L-Zn) as a nutritional feed additive for all animal species and categories. The applicant has provided evidence that, in essence, the additives under assessment comply with the proposed specifications. The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel) Panel concludes that zinc-lysinate sulfate in animal nutrition under the conditions of use proposed is safe for the target species and for the terrestrial and freshwater ecosystems. No conclusion can be drawn on its safety for the marine environment. In the absence of adequate data on zinc deposition, the FEEDAP Panel cannot conclude on the safety of the additive for the consumer. The additive is irritant to the skin and eyes and is a dermal and respiratory sensitiser. Exposure of users by any route is considered a risk and should be minimised. The Panel concludes that the additive is an efficacious source of zinc for all animal species.

PubMedEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2026-02-21

Optimizing ibuprofen dosing: insights from in vivo and virtual pharmacokinetic trials.

Smrčka David D, Ramesh Sreela S, Dumicic Aleksandra A, Beránek Josef J

Ibuprofen, a common non-steroidal anti-inflammatory drug (NSAID), is widely used in over-the-counter (OTC) settings for pain and fever management, with a maximum daily dose of 1200 mg recommended for non-prescription use. The clinical efficacy of ibuprofen is influenced by formulation-specific differences in drug release profiles. This study systematically compared four ibuprofen formulations: immediate-release (IR) 400 mg tablets, IR 200 mg tablets, lysinate salt equivalent to 400 mg ibuprofen, and a novel bi-layer tablet integrating immediate- and sustained-release (IR/SR) components. Both, in vivo pharmacokinetic (PK) data and physiologically based PK modeling were employed to evaluate absorption kinetics, plasma concentration-time profiles, and therapeutic duration. Plasma concentration thresholds of 6.8 µg/mL and 10.1 µg/mL were used to assess onset and duration of action. The IR/SR 400 mg bi-layer tablet maintained plasma concentrations above these thresholds for eight hours, extending therapeutic coverage by 2-3.5 h compared to other IR formulations. Virtual PK simulations indicated that only IR 200 mg (six doses/day) and IR/SR 400 mg (three doses/day) regimens sustained therapeutic levels over 24 h without surpassing OTC limits. The reduced dosing frequency and prolonged efficacy of the IR/SR formulation support its suitability for providing continuous pain and fever relief.

PubMedJournal of environmental management2025-10-13

Deciphering the role of non-covalent interactions in CO2 Capture: A DFT and COSMO-RS study of amino acid-based ionic liquids.

Karim Hira H, Sardar Sabahat S, Panditharatne Suhan Prasantha SP, Mumtaz Asad A et al.

A computational investigation into the interactions between amino acid based ionic liquids (AAILs) and carbon dioxide has provided valued discernments into the molecular mechanisms leading to CO2 capture. Using DFT and COSMO-RS simulations, the adsorption affinity of three AAILs based on lysinate, Arginate and Glycinate based amino acids anions tehthered with with counter cation 1-Methyl-3-(3-sulfopropyl)-imidazolium [1MeimPS]+ with CO2 is explored. The interaction of nCO2 (n = 1) with lysine based AAIL-1CO2 showed superior adsorption energy of -2.820 kcal/mol, whereas arginine based AAIL-1CO2 showed least adsorption energy of -1.966 kcal/mol. Similarly, for nCO2 (n = 2), the lysine based AAIL 2CO2 showed nearly double the adsorption energy of -4.6831 kcal/mol compared to lysine based AAIL 1CO2. On contrary, arginine based AAIL-2CO2 has even less adsorption energy of -1.901 kcal/mol compared to [1MeimPS][Arg]-1CO2. However, the introduction of second CO2 molecule reduces the bond distances for AAILs--1CO2, further strengthened and fine-tuned the CO2 adsorption. Also, CO2 solubility of AAILs is investigated ranging from 288.15 to 353.15 K at 5.0-45 bar revealed that temperature has inverse relationship with solubility, illustrating that the combination of [Gly]- and [Lys]- anions with cation [1MeimPS]+ is effective for efficient CO2 capture and separation. Furthermore, Natural Bond Orbital (NBO) analyis showed the significant charge trasfer in lysine based AAIL nCO2 compared to other ILs. Also, anions have the appreciable chances of strong dispersion interactions with CO2 as revealed by Quantum Atoms in Molecules (QTAIM), and Interaction Region Indicator (IRI) plots. Among, ILs bearing multiple amine groups, lysine based AAIL displayed favorable activity coefficient (γ∞) values suggesting efficient and stable interactions with CO2 as evidenced by Adsorption Energy Eads, QTAIM topologies and IRI isosurfaces. Understanding multiple interactions between ILs and nCO2 paved the ways to design ILs for CO2 adsorption and separation for environmental challenges.

PubMedEFSA journal. European Food Safety Authority2025-07-28

Safety and efficacy of a feed additive consisting of copper lysinate sulfate for all animal species (Phytobiotics Futterzusatzstoffe GmbH).

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa Roberto Edoardo RE, Azimonti Giovanna G, Bonos Eleftherios E et al.

Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of copper lysinate sulfate as nutritional feed additive for all animal species. The additive has not yet been authorised in the EU. The FEEDAP Panel concluded that the additive copper lysinate sulfate is safe for all animal species and categories at the respective maximum authorised total copper levels in feed. In the absence of reliable deposition data, the FEEDAP Panel could not conclude on the safety of the additive for the consumer. In the absence of data, the FEEDAP Panel could not conclude on the eye irritation potential of the additive. The Panel concluded that the additive is not a skin irritant and thus it should be considered a skin and respiratory sensitiser; inhalation and dermal exposure are considered a risk. The FEEDAP Panel concluded that the use of the additive under the proposed conditions of use is safe for the environment. The Panel was not in the position to conclude on the efficacy of the additive at the maximum authorised inclusion level.

PubMedPhysical chemistry chemical physics : PCCP2025-06-27

Intermolecular organization in aqueous mixtures of choline lysinate studied via NMR and molecular dynamics/quantum mechanics.

Sipavičius Einaras E, Mikalauskas Lukas L, Klimavicius Vytautas V, Aidas Kęstutis K

Aiming to scrutinize intermolecular organization in aqueous mixtures of the choline lysinate, [Cho][Lys], ionic liquid (IL), the dependence of the 1H NMR chemical shifts and diffusion coefficients on their composition was measured. To rationalize experimental findings, extensive molecular dynamics (MD) simulations and linear response quantum mechanics/molecular mechanics (QM/MM) computations of NMR shielding constants were performed. Analysis of MD trajectories reveals that the extent of intermolecular contacts between cations and anions intensifies with the increasing content of the IL in the mixture. Moreover, the tendency of choline cations and the side chains of lysinate anions to self-aggregate was observed as well, leading to the formation of a continuous, highly polar domain composed of choline cations and the carboxylate groups of lysinate anions, as well as a less polar domain formed by the side chains of the anions in IL-rich mixtures. Under these circumstances, isolated water pockets are found to be situated at the interface of the polar and nonpolar ionic domains. The dependence of the measured diffusion coefficients on the composition of the mixture reveals the existence of two dynamical regimes - fast and slow regimes below and above molar fraction of the IL of 11%, respectively. Results of MD simulations suggest that - at this specific molar composition of aqueous [Cho][Lys] mixture - continuous water network ceases giving way to the continuous structure of ionic domains being formed. The QM/MM results for the 1H NMR chemical shifts of aqueous IL mixtures generally agree well with experimental findings and corroborate structural results. The prominent upfield shift of the NMR signal of protons in fast exchange with the rising content of the IL was successfully rationalized.

+269 more articles available with a free account

Sign up free to view all articles →

Ask about bendazac lysinate